Ergotamine Tartrate and Caffeine |
Cafatine PB; Cafergot; Ercaf; Ergo-Caff; Migergot; Wigraine |
Cafergot is the proprietary name of a medication consisting of ergotamine tartrate or ergoline and caffeine. This combination is used for the treatment of vascular headaches, such as migraine headache. The molecular structure of ergotamine The molecular structure of caffeine Use Correct timing of use is important. Cafergot is an abortive headache treatment, which prevents the development of the headache, rather than a treatment for an established headache. The medication should ...
Wikipedia - [full article]
Ergotamine Tartrate and Caffeine Clinical Trials
- Assessment and Treatment of Caffeine Dependence
ClinicalTrials.gov Identifier: NCT00338195 - Recruiting
Self-Identified Problematic Caffeine Use; DSM-IV Substance Dependence as Applied to Caffeine
- Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
ClinicalTrials.gov Identifier: NCT00383643 - Recruiting
Chronic Insomnia
- A 12-Week Double-Blind, Placebo-Controlled, Multicenter Study with Varenicline Tartrate 1mg Bid for Smoking Cessation
ClinicalTrials.gov Identifier: NCT00155298 - Recruiting
Smoking
- Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
ClinicalTrials.gov Identifier: NCT00226096 - Active, not recruiting
CVA (Cerebrovascular Accident); Cerebral Hemorrhage; Intracranial Hemorrhages
- Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
ClinicalTrials.gov Identifier: NCT00205166 - Recruiting
Coronary Artery Disease
- Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD
ClinicalTrials.gov Identifier: NCT00363298 - Recruiting
Obsessive-Compulsive Disorder
- Caffeine for Apnea of Prematurity (CAP)
ClinicalTrials.gov Identifier: NCT00182312 - Active, not recruiting
Apnea of Prematurity
- Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients
ClinicalTrials.gov Identifier: NCT00495092 - Recruiting
Cocaine Related Disorders
- The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease
ClinicalTrials.gov Identifier: NCT00564824 - Recruiting
Coronary Disease
- Coronary Care Caffeine
ClinicalTrials.gov Identifier: NCT00137098 - Completed
Myocardial Infarction
- The Effect of Caffeine on Ischemic Preconditioning
ClinicalTrials.gov Identifier: NCT00184912 - Completed
Caffeine; Ischemic Preconditioning; Ischemia-Reperfusion Injury
- Combined Behavioral/Pharmacological Therapy for Insomnia
ClinicalTrials.gov Identifier: NCT00044629 - Recruiting
Sleep Initiation and Maintenance Disorders; Sleep Deprivation
- Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
ClinicalTrials.gov Identifier: NCT00471952 - Recruiting
Migraine With Aura; Migraine Without Aura
- Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
ClinicalTrials.gov Identifier: NCT00457652 - Recruiting
Ischemia Reperfusion Injury
- Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
ClinicalTrials.gov Identifier: NCT00283790 - Completed
Insomnia
- Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
ClinicalTrials.gov Identifier: NCT00413751 - Completed
Healthy
- A Study of Zolpidem Tartrate Lozenge in Adult Patients With Insomnia
ClinicalTrials.gov Identifier: NCT00466193 - Completed
Sleep Initiation and Maintenance Disorders
- Does Caffeine Help Children With Obstructive Sleep Apnea Recover Faster From Anesthesia and With Less Complication After Tonsillectomy and Adenoidectomy?
ClinicalTrials.gov Identifier: NCT00273754 - Recruiting
Sleep Apnea, Obstructive; Tonsillectomy and Adenoidectomy; Postoperative Complications
- A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients with Open-Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov Identifier: NCT00061529 - Completed
Open-Angle Glaucoma; Ocular Hypertension
- Caffeine and Intermittent Claudication
ClinicalTrials.gov Identifier: NCT00388128 - Recruiting
Intermittent Claudication
- Efficacy and Tolerability of DITROPANĀ® XL (Oxybutynin Chloride) Versus DETROLĀ® LA (Tolterodine Tartrate) in Treatment of Overactive Bladder
ClinicalTrials.gov Identifier: NCT00293839 - Completed
Urinary Incontinence
- An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
ClinicalTrials.gov Identifier: NCT00371813 - Completed
Smoking
- Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence
ClinicalTrials.gov Identifier: NCT00495183 - Not yet recruiting
Cocaine Dependence
- The Effect of Caffeine in Elderly Citizens
ClinicalTrials.gov Identifier: NCT00117520 - Completed
Healthy elderly citizens
- Caffeine in the Prevention of Post-Operative Nausea and Vomiting
ClinicalTrials.gov Identifier: NCT00130026 - Completed
POSTOP NAUSEA VOMITING
- Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00459420 - Recruiting
Parkinson's Disease; Excessive Daytime Somnolence
- A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
ClinicalTrials.gov Identifier: NCT00432562 - Completed
Breast Cancer; Non-Small Cell Lung Cancer; Non-Hodgkins Lymphoma
- Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis
ClinicalTrials.gov Identifier: NCT00264082 - Completed
Breast Cancer
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00104442 - Completed
Alzheimer's Disease
- Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov Identifier: NCT00250679 - Completed
Chronic Obstructive Pulmonary Disease; Bronchitis; Emphysema
- Experimental Studies of the Effects of Caffeine on Glucose Regulation
ClinicalTrials.gov Identifier: NCT00432887 - Completed
Diabetes Mellitus, Type 2
- Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function
ClinicalTrials.gov Identifier: NCT00487227 - Completed
Healthy
- Efficacy Study of Single-Dose Levalbuterol Tartrate Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI) Versus Placebo in Prevention of Exercise-Induced Bronchospasm (EIB) in Subjects 18 Years of Age and Older With Exercise-Induced Bronchospasm
ClinicalTrials.gov Identifier: NCT00268723 - Completed
Exercise-Induced Bronchospasm
- Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan
ClinicalTrials.gov Identifier: NCT00009542 - Completed
Healthy
- Determining the Risk Factors such as Smoking, Alcohol, and Caffeine and their Association with Osteoporosis in Men
ClinicalTrials.gov Identifier: NCT00011323 - Completed
Osteoporosis
- Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
ClinicalTrials.gov Identifier: NCT00430170 - Completed
Cardiovascular Disease; Ischemia-Reperfusion Injury
- Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia
ClinicalTrials.gov Identifier: NCT00253929 - Completed
Blood Flow in Healthy Volunteers
- Metabolic Capacity of Israeli Populations
ClinicalTrials.gov Identifier: NCT00162383 - Terminated
Healthy volunteers

Not Signed In -


